OBRinvest

OBRinvest is an online trading brand operated by OBR Investments Limited, a financial services firm headquartered in Limassol, Cyprus. The company was established in January 2021 and presents itself as a provider of forex and CFD trading services.

The broker's registered office is located at 161 Makarios III Avenue, 3027, 6th Floor, Akapnitis Court, Limassol, Cyprus. Despite being a relatively young entity, OBRinvest markets its operations under the regulatory umbrella of the Cyprus Securities and Exchange Commission (CySEC).

OBR Investments Limited holds a licence issued by CySEC under number 217/13, authorising the firm to operate as a Cyprus Investment Firm (CIF). This licence permits the company to offer investment services and activities, including reception and transmission of orders, execution of orders on behalf of clients, and dealing on own account.

As a CySEC-regulated entity, the broker is required to comply with the Markets in Financial Instruments Directive (MiFID II) and maintain membership in the Investor Compensation Fund (ICF), which theoretically protects eligible retail clients up to €20,000 in the event of the firm’s insolvency. The licence type is Market Making, meaning the firm can act as a dealing desk counterparty.

OBRinvest structures its offering around four distinct account categories, designed to accommodate a wide spectrum of capital levels. The entry-level Basic account requires a minimum deposit of €250 and offers leverage up to 1:30, in line with ESMA restrictions for retail clients. The Gold account starts at €25,000 with the same leverage cap.

At the higher end, the Platinum and VIP accounts demand €100,000 and €250,000 respectively, but unlock significantly higher leverage of up to 1:400. Spreads vary across tiers; VIP clients are quoted from 1.6 pips on EUR/USD, while Basic accounts see spreads from 3.0 pips. No commission charges are disclosed for any account type.

The broker does not explicitly name the trading platform it deploys on its website or in its promotional materials. User reviews occasionally allude to a functional and visually appealing platform, but no third-party verification (such as MetaTrader) is provided. This lack of transparency makes it difficult for prospective clients to evaluate the trading environment independently.

Given the regulatory status, the platform is expected to support typical order types, charting, and risk-management tools, but specifics remain unconfirmed.

OBRinvest advertises a diversified portfolio spanning several asset classes: cryptocurrencies, currencies, commodities, stocks, and indices. However, no detailed product list or contract specifications are publicly available. The company describes itself as a multi-asset broker, but the absence of concrete data on available symbols and trading conditions is a notable informational gap.

The broker’s website does not disclose accepted payment methods, processing times, or associated fees for deposits and withdrawals. This opacity extends to both funding and withdrawal procedures, leaving potential clients without critical information about how to transfer funds to and from their trading accounts.

While some user reviews mention successful deposits, the lack of official documentation on withdrawal channels is a significant concern, particularly in light of the numerous withdrawal-related complaints recorded by FXCanary.

The account structure suggests the broker aims to serve a broad audience, from retail traders with modest capital (via the Basic account) to high-net-worth individuals and professional clients (via Platinum and VIP). The high leverage offered on upper-tier accounts indicates a likely targeting of experienced traders willing to opt for professional status under MiFID, thereby forfeiting certain retail protections.

Given the regulatory framework, the basic offering is suitable only for EU retail traders who are protected by leverage caps and negative-balance protection, while the higher tiers may appeal to those who qualify as professional clients and accept elevated risk.